113 related articles for article (PubMed ID: 8216563)
1. Immunogenicity of low dose Japanese encephalitis vaccine (BIKEN) administered by the intradermal route: preliminary data.
Intralawan P; Paupunwatana S
Asian Pac J Allergy Immunol; 1993 Jun; 11(1):79-83. PubMed ID: 8216563
[TBL] [Abstract][Full Text] [Related]
2. Japanese encephalitis. Inactivated Japanese encephalitis virus vaccine.
Wkly Epidemiol Rec; 1994 Apr; 69(16):113-8. PubMed ID: 8003406
[No Abstract] [Full Text] [Related]
3. Japanese encephalitis vaccine (inactivated, BIKEN) in U.S. soldiers: immunogenicity and safety of vaccine administered in two dosing regimens.
Defraites RF; Gambel JM; Hoke CH; Sanchez JL; Withers BG; Karabatsos N; Shope RE; Tirrell S; Yoshida I; Takagi M; Meschievitz CK; Tsai TF
Am J Trop Med Hyg; 1999 Aug; 61(2):288-93. PubMed ID: 10463681
[TBL] [Abstract][Full Text] [Related]
4. Japanese encephalitis vaccines.
Wkly Epidemiol Rec; 1998 Oct; 73(44):337-44. PubMed ID: 9817024
[No Abstract] [Full Text] [Related]
5. Intradermal boosting of Japanese encephalitis vaccination.
Kitchener S; Baade L; Brennan L; Nasveld P
J Travel Med; 2004; 11(3):182-3. PubMed ID: 15710061
[No Abstract] [Full Text] [Related]
6. Evaluation of effectiveness of mouse brain inactivated Japanese encephalitis vaccine produced in India.
Gowal D; Tahlan AK
Indian J Med Res; 1995 Dec; 102():267-71. PubMed ID: 8557319
[TBL] [Abstract][Full Text] [Related]
7. Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep; 1993 Jan; 42(RR-1):1-15. PubMed ID: 8381504
[TBL] [Abstract][Full Text] [Related]
8. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
9. Safety, immunogenicity, and protective efficacy of NYVAC-JEV and ALVAC-JEV recombinant Japanese encephalitis vaccines in rhesus monkeys.
Raengsakulrach B; Nisalak A; Gettayacamin M; Thirawuth V; Young GD; Myint KS; Ferguson LM; Hoke CH; Innis BL; Vaughn DW
Am J Trop Med Hyg; 1999 Mar; 60(3):343-9. PubMed ID: 10466959
[TBL] [Abstract][Full Text] [Related]
10. Effect of current Japanese encephalitis vaccine on different strains of Japanese encephalitis virus.
Okuno Y; Okamoto Y; Yamada A; Baba K; Yabuuchi H
Vaccine; 1987 Jun; 5(2):128-32. PubMed ID: 3037813
[TBL] [Abstract][Full Text] [Related]
11. Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study.
Erra EO; Askling HH; Yoksan S; Rombo L; Riutta J; Vene S; Lindquist L; Vapalahti O; Kantele A
Vaccine; 2013 Dec; 32(1):119-23. PubMed ID: 24176496
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains.
Kurane I; Takasaki T
Vaccine; 2000 May; 18 Suppl 2():33-5. PubMed ID: 10821971
[TBL] [Abstract][Full Text] [Related]
13. Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis.
Paulke-Korinek M; Kollaritsch H; Kundi M; Zwazl I; Seidl-Friedrich C; Jelinek T
Vaccine; 2015 Jul; 33(30):3600-4. PubMed ID: 26036947
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Japanese encephalitis virus DNA vaccine candidates in rhesus monkeys [Macaca mulatta].
Bharati K; Rani R; Vrati S
Vaccine; 2009 Jan; 27(1):10-6. PubMed ID: 18996161
[TBL] [Abstract][Full Text] [Related]
15. Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine.
Konishi E; Yamaoka M; Kurane I; Mason PW
Virology; 2000 Mar; 268(1):49-55. PubMed ID: 10683326
[TBL] [Abstract][Full Text] [Related]
16. Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: a randomized, observer-blind, controlled Phase 3 study.
Schuller E; Klade CS; Wölfl G; Kaltenböck A; Dewasthaly S; Tauber E
Vaccine; 2009 Mar; 27(15):2188-93. PubMed ID: 19200452
[TBL] [Abstract][Full Text] [Related]
17. Immunisation against Japanese encephalitis in Nepal: experience of 1152 subjects.
Henderson A
J R Army Med Corps; 1984 Oct; 130(3):188-91. PubMed ID: 6098647
[TBL] [Abstract][Full Text] [Related]
18. Further experience with Japanese encephalitis vaccine.
Sanchez JL; Hoke CH; McCown J; DeFraites RF; Takafuji ET; Diniega BM; Pang LW
Lancet; 1990 Apr; 335(8695):972-3. PubMed ID: 1970043
[No Abstract] [Full Text] [Related]
19. Is a booster dose necessary in children after immunization with live attenuated Japanese encephalitis vaccine?
Choi UY; Lee SY; Kim KH; Kim DS; Choi KM; Cha SH; Kang JH
J Trop Pediatr; 2013 Oct; 59(5):423-5. PubMed ID: 23764540
[TBL] [Abstract][Full Text] [Related]
20. A field trial of Japanese encephalitis vaccine produced in Thailand.
Rojanasuphot S; Charoensuk O; Kitprayura D; Likityingvara C; Limpisthien S; Boonyindee S; Jivariyavej V; Ugchusak K
Southeast Asian J Trop Med Public Health; 1989 Dec; 20(4):653-4. PubMed ID: 2561722
[No Abstract] [Full Text] [Related]
[Next] [New Search]
